More PRNewswire
View Older Stories View Newer Stories-
Enzyme Innovation's New Study on the Stability & Effect of Bacillus coagulans LBSC on the Sensory Attributes of Food Products was Published in the Global Journal of Microbiology and Biotechnology
-
American University Fall Commencement to Feature Surgeon General Dr. Vivek H. Murthy
-
FP Markets Awarded FX Broker Licence in Kenya by the Capital Markets Authority (CMA)
-
GEORGIA TECH TRANSIT TEAMSTERS OVERWHELMINGLY RATIFY CONTRACT
-
Aeromexico November 2023 Traffic Results
-
ZEN LEAF CANNABIS WORKERS IN ROGERS PARK JOIN TEAMSTERS LOCAL 777
-
NPA Says House of Representatives' Passage of Bill to Provide Veterans Additional Access to the Program of All-Inclusive Care for the Elderly Will Improve Their Lives; Urges Swift Senate Passage
-
DAISO NEW STORE OPENING IN PHOENIX, ARIZONA
-
Cisco Redefines Cybersecurity Defense with Powerful, Portfolio-Wide Artificial Intelligence Capabilities
-
SANTA CLARITA TRANSIT WORKERS RATIFY CONTRACT, END STRIKE
-
Emmy Award-Nominated Actor Ed Begley, Jr. To Receive 13th Annual Experience, Strength And Hope Award For His Recently Published Book: "To the Temple of Tranquility...And Step On It!: A Memoir&quo
-
Paleblue to Debut in REI Retailers Nationwide
-
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
-
Smithfield Foods to End Grower Contracts in Utah
-
Bit Digital, Inc. Announces Monthly Production Update for November 2023
-
JPAR® Continues Nationwide Growth with Florence, Alabama Franchise Office
-
FDA Roundup: December 05, 2023
-
Dell Technologies Declares Quarterly Cash Dividend
-
Calumet to Attend Wells Fargo Conference
-
FDA Implements AADA's iPLEDGE Recommendations
-
George Washington University Competition Law Center and Crowell & Moring Host Fifth Annual Antitrust and Tech Conference
-
Nearmap Announces Agreement to Acquire Betterview, a Complementary Property Intelligence and Risk Management Platform
-
Young Innovations Announces Acquisition of Salvin Dental Specialties
-
Tralucent Asset Management Closes the Market
-
A Film For All Seasons
-
SIGMA LITHIUM FEATURED AT COP-28 FOR ITS CLEAN TECHNOLOGY, PIONEERING PRACTICES IN ENVIRONMENTAL SUSTAINABILITY AND POSITIVE SOCIAL IMPACT FOR A FOURTH YEAR
-
Veteran Ventures Capital Invests in Biomaterials Science Pioneer, Cambium, to Fuel Innovative Defense Technology Advancements
-
CBOE GLOBAL MARKETS REPORTS TRADING VOLUME FOR NOVEMBER 2023
-
GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING
-
Danaher Announces Quarterly Dividend
-
PNM Resources Increases Common Dividend 5.4%
-
Harbour Group Partners with Texcel
-
How To Increase Average Order Value with 3D
-
Universal Technical Institute to Consolidate Houston Operations to Better Serve Students
-
PTC Therapeutics Provides Updates on Translarna™ Regulatory Activities
-
ONEOK to Participate in Wells Fargo Midstream and Utilities Symposium
-
CALIFORNIA FIRST LEASING CORPORATION ANNOUNCES PRELIMINARY RESULTS OF TENDER OFFER
-
Regal Rexnord Corporation Announces Publication Of Annual Sustainability Report
-
Anju Software Celebrates One Year Since the Launch of Their CRO Partner Program
-
Aspen Aerogels, Inc. Announces Additional EV Thermal Barrier Commercial Award and Provides Update on U.S. Department of Energy Loan Application Status
-
Terex Scores 100 on the 2023-2024 Corporate Equality Index
-
HERITAGE Partners with EXPOCAD for Groundbreaking Design and Quoting Integration
-
MongoDB Appoints Ann Lewnes to Board of Directors
-
MongoDB, Inc. Announces Third Quarter Fiscal 2024 Financial Results
-
Sterling Announces Authorization of a $200 Million Stock Repurchase Program
-
BetMGM CEO and CFO to participate in 2023 Morgan Stanley Global Consumer and Retail Conference
-
RADIANT LOGISTICS ANNOUNCES RENEWAL OF ITS STOCK REPURCHASE PROGRAM
-
Julian Mitton MD Unveils Grant for Mental Health Professionals Supporting Innovation and Excellence
-
Novavax's Updated COVID-19 Vaccine Now Authorized in Canada
-
Neurocrine Biosciences Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia
